PSA
60
5
EMN
50
-5
NOC
54
4
KHC
17
8
ISRG
77
2
M
36
-6
COST
66
6
AAPL
45
2
HRB
59
-7
STI
17
10
MET
60
2
TAP
58
-2
WBA
47
-3
WMT
63
3
MTCH
26
-7
GE
71
7
TSN
42
4
SYF
93
-2
WHR
70
2
PHM
63
4
PSA
60
5
EMN
50
-5
NOC
54
4
KHC
17
8
ISRG
77
2
M
36
-6
COST
66
6
AAPL
45
2
HRB
59
-7
STI
17
10
MET
60
2
TAP
58
-2
WBA
47
-3
WMT
63
3
MTCH
26
-7
GE
71
7
TSN
42
4
SYF
93
-2
WHR
70
2
PHM
63
4
Financhill
Back

Crinetics Pharmaceuticals Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
76

CRNX
Crinetics Pharmaceuticals

Last Price:
60.68
Seasonality Move:
5.63%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Crinetics Pharmaceuticals Price Quote

$60.68
-0.01 (1.56%)
(Updated: November 9, 2024 at 5:20 AM ET)

Crinetics Pharmaceuticals Key Stats

Buy
76
Crinetics Pharmaceuticals (CRNX) is a Buy
Day range:
$58.98 - $60.93
52-week range:
$25.75 - $60.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.85%
Volume:
573.3K
Avg. volume:
770K
1-year change:
113.32%
Market cap:
$4.9B
Revenue:
$4M
EPS:
$-3.78

How Much Does Crinetics Pharmaceuticals Make?

Data Unavailable

Is Crinetics Pharmaceuticals Growing As A Company?

Crinetics Pharmaceuticals Stock Price Performance

What Is Crinetics Pharmaceuticals 52-Week High & Low?

Crinetics Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Crinetics Pharmaceuticals?

Is Crinetics Pharmaceuticals Cash Flow Positive?

  • What Is CRNX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$178.3M
  • What Is Crinetics Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $774.9M
  • What Is Crinetics Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$333.9M

Crinetics Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    CRNX return on invested capital is -42.43%
  • What Is Crinetics Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -37.11%
  • What Is CRNX Return On Equity?
    ROE is a measure of profitability and is -42.43%

Crinetics Pharmaceuticals Earnings Date & Stock Price

Crinetics Pharmaceuticals Competitors

Crinetics Pharmaceuticals Dividend Yield

Crinetics Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -8.79%
Revenue: -59.62% -14.61%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 70.07
Upside from Last Price: 15.46%

Major Shareholders

  • How many CRNX shares are owned by institutional investors?
    128.7M CRNX shares are owned by institutional investors
  • How many CRNX shares are owned by insiders?
    950K CRNX shares are owned by insiders